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Enteropathogenic Escherichia coli (EPEC) colibacillosis represents a major cause of lethal diarrhea in young
children in developing countries. EPEC strains also infect numerous mammal species and represent a major
economical problem in rabbit industry. Protection against this pathogen is a challenging goal both in humans
and in other mammal species. Despite a good knowledge of the pathogenicity mechanisms of EPEC, the
intrinsic and environmental factors that control the expression of EPEC virulence in mammals remain
unknown. For instance, the exacerbated sensitivity of young mammals to EPEC infection is still unexplained.
Our goal was to investigate if age or other factors, like milk consumption, could be determinants that trigger
the disease. We used rabbits as an animal model to study the role of milk in the sensitivity to an EPEC
infection. Weaned and suckling rabbits were orally inoculated with EPEC strain E22 (O103:H2:K) at 28 days
of age, and the evolution of the disease was investigated in the two groups. In addition, in order to better
characterize the interactions between milk and EPEC, we determined in vitro bacterial growth and the abilities
of EPEC cells to adhere to epithelial cells in the presence of milk. Our results demonstrate a protective role of
milk in vivo in association with in vitro antibacterial activity. These effects are independent of the presence of
specific anti-EPEC antibodies.
Colibacillosis is a frequent disease in European rabbittries.
Depending on the geographical area, different serogroups of
Escherichia coli strains are predominant (3, 8). In France,
strains belonging to the O103 serogroup and to the rhamnose-
negative biotype are largely dominant among pathogenic E.
coli strains (8), and their high virulence leads to important
economic losses in farms due to high mortality rates, growth
retardation, and treatment costs. These strains induce severe
and lethal diarrhea in rabbits upon oral inoculation with as
little as 104 CFU (32). O103 rhamnose-negative strains are
currently classified as enteropathogenic E. coli (EPEC)-like
strains and represent strains similar to human EPEC strains in
their virulence mechanisms and pathology (12, 38). Because
EPEC strains isolated from humans do not cause diarrhea in
animals, rabbit strains from an EPEC-like pathovar (REPEC)
have been proposed as a model for the study of EPEC affecting
both humans and animals (31). Indeed, the locus of enterocyte
effacement of these REPEC strains is organized in similar
clusters of genes homologous to those identified in human
EPEC strains (12, 22, 34). As with human EPEC strains, the
characteristic attaching/effacing lesion provoked by REPEC
O103 strains is characterized by intimate adhesion to the cell in
cup-like pedestals associated with a localized degeneration of
host cell microvilli (1, 24, 34, 38).
However, REPEC strains differ from human EPEC strains
in that they do not express bundle-forming pili or any other
identifiable type 4-like fimbriae, responsible for the first loose
attachment of bacteria to enterocytes (38). Instead, a majority
of REPEC O103 isolates produces a specific fimbrial adhesin,
termed adhesive factor/rabbit 2 (AF/R2), which is responsible
for the adhesion to enterocytes and HeLa cell lines (30). This
adhesin shares homology with the K88 fimbrial adhesin (16).
Even if the etiological agent and its pathogenicity are now
well known, many uncertainties still exist with regard to the
intrinsic and environmental factors that control the expression
of EPEC virulence in mammals. In rabbit production farms,
weaned animals are more sensitive than suckling ones to in-
fection with O103 E. coli strains, with 4- to 5-week-old pups
being the most affected (23). In agreement with these obser-
vations, epidemiological studies with humans have shown that
breast-feeding is protective against infections with EPEC
strains (2). This has led to several hypotheses, including the
presence of specific receptors to E. coli on the intestinal epi-
thelium for a given period of age, the negative impact of
weaning for intestinal balance, and a more or less specific
protection by maternal milk mediated by antibodies and vari-
ous other substances. One main problem is that predisposition
factors that may affect the sensitivities of young mammals to
EPEC infections, like age or nutritional status (suckling or
weaned), are often confused in experimental or epidemiolog-
ical studies. However, understanding of the mechanisms un-
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derlying the sensitivities of young mammals to colibacillosis
due to EPEC strains is essential to effectively battle this disease
in the future. Indeed, applications not only can be found for
rabbit production but also can be extended to human health,
notably, in certain parts of the developing world where EPEC
is known to be an important cause of children mortality (33).
In this study, our goal was to investigate if age was essential
for the trigger of the disease or if other factors, like milk
consumption, could be determinants. We studied the sensitiv-
ities of weaned and suckling rabbits to an infection with an
EPEC strain known to preferentially affect 4- to 5-weeks-old
rabbits. Weaned and suckling rabbits were experimentally in-
oculated with EPEC strain E22 (O103:H2:K) at 28 days of
age, and the evolution of the disease was investigated in the
two groups. In addition, we carried out in vitro tests to under-
stand the role of milk in the expression of the disease. We
determined bacterial growth and the abilities of EPEC cells to
adhere to epithelial cells in the presence of milk. Our results
show a protective role of milk in vivo in association with an in
vitro antibacterial activity.
MATERIALS AND METHODS
Experimental infections. This experiment was carried out with PS Hyplus 19
PS Hyplus 39 rabbits (Grimaud group) from a breeding unit free of E. coli
contamination. Litters, normalized to nine kits, were weaned either at 21 days
(W21 group, five litters) or 35 days of age (W35 group, five litters). The envi-
ronmental temperature was maintained at 19  3°C. The lighting schedule was
7:00 to 23:00 h with the lights on. From 14 days of age, young rabbits had access
to an experimental feed (on an as-fed basis, crude protein, 17.3%; nondigested
fibers, 34.3%; starch, 9.1%), whereas does were fed with a commercial feed.
None of the diets was supplemented with antibiotics. Water and feed were
provided ad libitum. At this time, the does were separated from their pups,
except for suckling. The does were moved to new cages, whereas young rabbits
remained in their birth cage until the end of the experiment (63 days of age),
unless they were moved to new cages to respect density standards. Indeed, if
more than five rabbits from the same litter reached 35 days of age, half of the
litter was moved to another cage by alternating the weight ranks. Does were not
inseminated during the suckling period. Animals were handled according to the
care of animals in experimentation, in agreement with French national legisla-
tion (decree 2001-486, 06/06/2001), and the study received approval from the
regional ethical committee of Midi-Pyrenees (France).
Bacterial strains. An EPEC strain belonging to the O103:H2:K serotype
(strain E22) was used. This strain, described previously (4, 8, 30), does not
metabolize rhamnose and is AF/R2 fimbria positive. REPEC strain E22 was
cultured overnight at 37°C with shaking in Luria-Bertani (LB) broth. All young
rabbits were inoculated at 28 days of age by the oral route with 1 to 2 ml of a
phosphate-buffered saline (PBS) solution containing 104 CFU per ml, which
corresponds to 1 50% lethal dose of this strain (4). The rabbits in the W35 group
were infected 3 h after suckling.
For the inhibition of adhesion assay, we used a genetically modified pEGFP-
E22 strain (5). pEGFP-E22 was cultured in Penassay broth (antibiotic medium 3;
Difco) supplemented with 25 g/ml of carbenicillin, as described previously (5).
Clinical follow-up. From birth until the time of infection, the mortality of the
rabbits was controlled every day and each rabbit underwent a clinical examina-
tion twice a week. From 28 days onwards, mortality checking was done at least
twice a day, and a clinical examination was performed each morning. Prostration,
loss of appetite, diarrhea, and dehydration were systematically checked for.
When required, to shorten the length of suffering, the rabbits were euthanized
after anesthesia with an intramuscular injection of ketamine (Imalge`ne 1000),
followed by an intracardiac injection of a solution containing embutramide,
mebezonium, and tetracaine (T 61). An autopsy was carried out for each dead
rabbit to detect macroscopic lesions. The cecal content was sampled for bacterial
analysis (see below). The enumeration of E. coli E22 in the cecal contents,
combined with a postmortem examination of the lesions, permitted the identi-
fication of rabbits that had died from colibacillosis.
Bacterial analysis. Twice a week, a sample of feces (about 10 g) from the
different cages was collected to carry out bacterial analysis. At 63 days of age, all
the young rabbits were killed, and enumeration of the E. coli cells in the cecal
contents of individual rabbits was done. Cecal and fecal content enumeration of
E. coli cells was performed by plating 10-fold dilutions of samples on eosin-
methylene blue agar medium. After 24 h of incubation at 37°C, followed by a
selective enumeration (dark blue colonies), screening for the inoculated strain
was done with a set of randomly selected isolates (10 per sample) by using
rhamnose as a marker. The growth of E. coli was evaluated on a phenol red agar
containing 1% rhamnose (24 h, 37°C). In the case of doubtful biochemical
characteristics of the colonies, a slide agglutination test was done with specific
antibodies directed toward the O103 lipopolysaccharide (LPS) (7).
Preparation of milk and lactoserum. Seven suckling does kept in an area free
of the O103:H2 REPEC strain were used. The does were intravenously injected
with 3 IU of ocytocin at the time of suckling. After a brief contact with their pups,
the does were milked with a vacuum pump connected to a milker tube. For each
doe, between 2 and 10 ml of milk was obtained and kept at 4°C before testing.
Blood was also sampled from these does, and the sera were kept at 20°C.
Sampling was done at 17, 24, and 30 days after birth.
To obtain lactoserum, cold acetic acid was added to the milk to lower the pH
to a value of 3. The milk was immediately centrifuged at 10,000 rpm for 20 min
at 4°C. The clot was removed and the pH was adjusted to 7 by addition of 4 N
NaOH. An aliquot of serum from these does was subjected to the same treat-
ment, prior to its use in the tests for the inhibition of adhesion.
Bacterial growth in milk or lactoserum. Strain E22, which was cultured in LB
broth for 5 h at 37°C with rotary shaking (250 rpm), was transferred in milk for
18 h under the same conditions. From this culture, 100 l of a 106 dilution was
added to 400 l of milk, lactoserum, or LB broth medium (approximately 102
CFU). The same amount of overnight culture was spread onto an LB agar plate
to determine the exact amount of bacteria added to the medium. The bacteria
were cultured for 5 h at 37°C with rotary shaking (250 rpm). For counting of the
bacteria, dilutions of media were spread on LB agar plates in duplicate, the
plates were cultured overnight, and the numbers of CFU were determined for
each culture.
Quantification of bacterial adhesion on HeLa cells. HeLa cells (ATCC
CCL-2) were seeded at 5  104 cells per ml in 12-well plates (Nunc) and
cultivated for 24 h in Eagle minimum essential medium (MEM) supplemented
with 10% fetal calf serum (FCS; Gibco BRL), glutamine (2 mM) (Sigma), and
gentamicin (80 g/ml) at 37°C in a 5% CO2–95% air atmosphere. Strain pEGFP-
E22 was precultured for 24 h in Penassay broth (antibiotic medium 3; Difco)
supplemented with 25 g/ml of carbenicillin. Incubation of the bacteria with the
cells was realized in 500 l of MEM buffered with 5% FCS and 1% mannose,
with a starting inoculum of 20 l (about 2  107 bacteria per well). To test the
inhibitory capacity of adhesion of the serum, milk, or lactoserum of the does, 20
l of strain pEGFP-E22 bacteria grown overnight (109 CFU/ml) in Penassay
broth was preincubated with different amounts of serum, milk, or lactoserum for
1 h at room temperature, prior to incubation for 30 min with HeLa cells, as
described previously (5). After 30 min of incubation of the cells with the bacteria
at 37°C, the cells were washed three times with PBS. The cells were then
incubated for 15 min at 37°C in PBS containing 2 mM EDTA. The cells were
harvested in PBS, washed two times in PBS, and immediately acquired with a
Facscalibur instrument (Becton Dickinson). A total of 104 HeLa cells were
acquired per sample. Quantification of adhesion was monitored by using
Cellquest software (Becton Dickinson).
The percentage of inhibition was calculated by using the following formula:
(percentage of pEGFP-E22-positive HeLa cells without serum, milk, or lac-
toserum  percentage of pEGFP-E22-positive HeLa cells preincubated with
serum, milk, or lactoserum)/percentage of pEGFP-E22-positive HeLa cells with-
out serum, milk, or lactoserum.
Tissue sampling for immunohistochemical studies. A litter of nine suckling
New Zealand rabbits and a litter of weaned rabbits (group W21) were orally
inoculated with 2  104 CFU of strain E22 at day 28 and housed as described
above. The animals in each group were killed at 3 days postinfection by intra-
venous overdosing with sodium pentobarbital. Tissues from the distal ileum (10
cm from the ileo-cecal junction) were removed immediately after euthanasia.
The tissues were fixed in 10% formaldehyde and embedded in paraffin. Trans-
versal tissue sections (3 m) were used for immunochemical staining. The slides
were treated with hydrogen peroxidase and an ABC kit (Vector, Burlingame,
CA) to remove the background before staining. The bacteria fixed on the epi-
thelia were labeled by using serum prepared in the laboratory by intradermal
injection of a sheep with formalin-fixed whole E22 (4). To detect the fixation of
anti-E22 antibodies, we used a biotinylated anti-sheep immunoglobulin antibody
(Vector Laboratories). Anti-sheep immunoglobulin fixation was revealed with
streptavidin coupled with peroxidase (Vector Laboratories) and revealed with
diamino-benzidine (Sigma). All tissue samples were scored blindly by using light
microscopic observations (Leica).
Statistical analysis. For each age, a designations of 0 or 1 was attributed to
each rabbit if it was dead or alive, respectively. These data, which are considered
Bernoulli variables, were submitted to a variance analysis (GLM procedure;
SAS, 1999); the effect of weaning age on the survival rate was tested. For E. coli
excretion, the results were expressed in log10 CFU  g1 of sampled feces.
Among the E. coli cells excreted, the proportion of the infectious strain corre-
sponded to the number of colonies not metabolizing the rhamnose among those
tested. The effect of the weaning age on total fecal excretion of E. coli was
analyzed by the GLM procedure (SAS, 1999).
RESULTS
Suckling temporarily protects young rabbits from colibacil-
losis. In the experiment performed to determine whether suck-
ling temporarily protects young rabbits from colibacillosis, we
took several precautions in the experimental setting. First, the
does had to be seronegative for the strain of E. coli used here,
to exclude any humoral passive protection for the young by the
maternal milk. Second, the kits should not show any sign of
previous contact with this strain. Thus, all does were tested for
the presence of anti-LPS O103 antibodies 10 days before par-
turition and were found to be seronegative (data not shown).
Their 24-day-old kits were also seronegative (28% of rabbits
randomly tested), and no E. coli strains metabolizing the rham-
nose were found in their fecal output (all cages were tested)
(data not shown).
The two groups of young rabbits were inoculated 28 days
after birth, and mortality was determined daily. The origin of
each death was assessed by a combination of bacterial analysis
of the cecal contents and necropsic examination. Colibacillosis
was not responsible for the deaths of six rabbits: one rabbit
from the W21 group and five rabbits from the W35 group. The
data for these animals were removed from the study.
Our results indicate that after inoculation of E22, the mor-
tality presented different patterns of evolution according to the
nutritional status of the young rabbits (Fig. 1). Indeed, the first
deaths were observed in the weaned group (group W21) from
day 4 after experimental infection. In sharp contrast, no mor-
tality due to colibacillosis was noticed in the suckling group
(group W35) until 8 days postinfection (36 days of age), with
the first death occurring only 1 day after weaning. At that time
point, 50% of the group W21 rabbits were already dead. This
mortality rate was reached only on day 45 in the W35 group.
Moreover, the disease developed quickly in the W21 group,
with the final survival rate being 20% 13 days after the first
death occurred, whereas this evolution was slower for group
W35 rabbits (mortality was observed over a period of 19 days).
From 33 to 49 days of age, the survival rate of group W35
rabbits was higher than that of group W21 rabbits (P  0.05).
However, the difference in the final mortality rate between the
two groups (36% for the W35 group versus 20% for the W21
group) was not statistically significant (P  0.102).
As for mortality, the morbidity of the rabbits was recorded
daily. The main clinical signs observed in rabbits during this
study were prostration, weight loss, anorexia, and abundant
aqueous diarrhea sometimes accompanied by dehydration
symptoms. The same time lag in the pattern for mortality
between the two weaning groups was noticed for the pattern of
morbidity (Fig. 2). Thus, the peak of morbidity was observed at
32 days of age in the W21 group (close to 74% of diarrheic
rabbits) but was observed at 42 days of age for rabbits in the
W35 group (about 52% of morbid rabbits). Morbidity reached
100% for the whole period of the study, and all rabbits pre-
sented diarrhea symptoms in at least one clinical assessment,
whatever their weaning group.
Suckling temporarily limits fecal E. coli excretion. To study
the development of colibacillosis and to evaluate intestinal
colonization and the potential elimination of pathogenic bac-
teria by rabbits, we aimed at controlling the level of fecal E. coli
excretion. Fecal excretion of resident E. coli was unaffected by
the weaning age before challenge, namely, 24 and 28 days of
age (Fig. 3). After oral inoculation, group W21 rabbits ex-
creted more pathogenic E. coli than group W35 rabbits until 38
days of age (3.4 log [P  0.05], 2.4 log [P  0.001], and
1.3 log [P 0.053] at 31, 36, and 38 days of age, respectively).
From 42 days onwards, the excretion patterns became similar
between the two weaning groups and remained high until 49
FIG. 1. Suckling protects young rabbits from lethal colibacillosis
due to an EPEC O103 strain. Rabbits in the W21 group (black
squares) and the W35 group (gray squares) were inoculated by the oral
route on day 28 with 2  104 CFU of the EPEC O103 E22 strain. The
mortality rate of 50% was reached at 36 days of age in the W21 group
and at 45 days of age in the W35 group. Final survival rates were of
20% and 36% in the group W21 and group W35 rabbits, respectively
(P  0.102).
FIG. 2. Suckling delays the evolution of diarrhea in young rabbits
infected with an EPEC O103 strain. Diarrhea signs were recorded for
rabbits in the W21 group (black) and the W35 group (gray) after
experimental infection with the E22 strain of EPEC on day 28. This
graph represents the daily evolution of the number of deaths among
surviving rabbits. The number of surviving rabbits is represented by the
shaded area, and the number of deaths is represented by fully colored
area for each group.
days of age (	106 CFU  g1 of feces). The profile of bacterial
excretion clearly corresponded to the evolution of clinical signs
in the two experimental groups. After day 49, the levels were
maintained at 104 pathogenic E. coli  g1 until 59 days of age,
whatever the weaning age, but with a high variability between
rabbits. In the W35 group, this variability could be explained by
the elimination of the inoculated strain from some cages (three
cages on day 56 and eight cages on day 59). In the group W21
rabbits, this phenomenon may result from the low number of
remaining cages (only four cages on day 42 and seven cages on
day 35). Individual cecal enumeration of E. coli at 63 days of
age revealed that about half of the survivors had eliminated
EPEC, whatever their weaning age (4/8 rabbits in the W21
group and 6/11 rabbits in the W35 group).
Bacterial adhesion to the ileal epithelium is strongly re-
duced in suckling rabbits. We next wondered if the differential
clinical evolution and the differential levels of fecal excretion
between weaned and suckling rabbits were associated with
differential ileal bacterial attachment and tissue lesions. A lit-
ter of weaned rabbits and one of the suckling rabbits were
killed 3 days after oral inoculation with E22. Ileal tissues were
sampled and stained with an anti-E22 serum, as described in
Material and Methods.
In all weaned rabbits, we observed an important bacterial
adhesion to the ileal epithelium. Bacteria almost entirely cov-
ered the epithelium, and we could detect the intimate attach-
ment of bacteria to enterocytes, a typical lesion characteristic
of EPEC (Fig. 4a). This strong bacterial adhesion was associ-
ated with a modification of the ileal architecture, characterized
by the atrophy of the villi and the desquamation of the epithe-
lium. At the time of sampling, all rabbits were prostrate and
about 50% of them already presented with diarrhea.
In contrast, bacterial adhesion was greatly reduced in suck-
ling rabbits. Among nine rabbits tested, eight exhibited rare
FIG. 3. Suckling limits fecal excretion of E. coli by young rabbits
infected with an EPEC O103 strain. The total excretion of E. coli was
recorded twice a week in all cages and is represented by the heights of
the bars (in black and gray for the group W21 and W35 rabbits,
respectively). Among the E. coli cells excreted, the proportion that was
E22 (solid bars) was determined. Data show the arithmetic means 
standard deviations. For each time sampling, P values between groups
W21 and W35 are shown on the graph for the W35 group for P values
of 0.10 (), 0.01 (), and 0.05 (†).
FIG. 4. Suckling prevents ileal bacterial attachment and intestinal
inflammation. Ileal tissue sections of weaned (a) or suckling (b and c)
rabbits infected at day 28 and killed at day 31 were stained with
anti-E22 sera and visualized with a Leica microscope. (a) All weaned
rabbits presented an ileal epithelium covered by intimately attached
E22 bacteria (arrow). Note the strong tissue destruction characterized
by villous atrophy and the afflux of inflammatory cells. (b) Eight of nine
suckling rabbits presented only scarce bacterial adhesion (arrow). Villi
are intact, and no sign of inflammation is visible. (c) One suckling
rabbit presented a more important bacterial attachment to the epithe-
lium (arrow). This adhesion was associated with shortening and wid-
ening of the villi. Magnifications, 400.
bacterial adhesion, with only scarce spots of bacteria detected
(Fig. 4b). In addition, the epithelium was intact and no inflam-
matory lesions were detected. The villi remained long and thin.
None of these rabbits presented with clinical signs at the time
of sampling. The remaining rabbit presented a more important
E22 intestinal colonization. About 30% of the ileal epithelium
was covered by bacteria (Fig. 4c). The attachment of E22 was
associated with an intermediate inflammatory response, char-
acterized by a shortening and a widening of the villi; however,
it was not associated with epithelial desquamation. Interest-
ingly, this rabbit did not display any clinical signs.
These results confirm a protective effect of milk ingestion
against colibacillosis. Indeed, we demonstrated a strong differ-
ence in bacterial attachment to the epithelium between suck-
ling and weaned rabbits. In addition, this reduced adhesion was
not associated with important intestinal lesions.
Milk and lactoserum have bacteriostatic effects in vitro. The
in vivo results prompted us to characterize the protective effect
of doe’s milk in vitro. In order to define a potential bacterio-
static or bactericidal effect of doe’s milk on REPEC growth,
E22 bacteria grown in doe’s milk were cultured for 5 h in LB
medium, milk, or lactoserum, as described in Materials and
Methods. Our results showed the clear bacteriostatic effects of
milk (2 log units of growth reduction compared with the
growth in LB medium) and lactoserum (more than 3 log units
of growth reduction compared with the growth in LB medium)
(Fig. 5). Interestingly, the bacteriostatic effect of lactoserum
was almost complete. Indeed, the growth rate was equal to only
1.3 after 5 h of culture. However, we could not demonstrate
any bactericidal effect of milk or lactoserum in vitro.
Thus, the protective effect of suckling against REPEC for
young rabbits seems to be associated with a capacity to limit
bacterial growth in vitro.
Milk and lactoserum inhibit bacterial adhesion in vitro. We
previously developed an in vitro test to quantify the capacity of
rabbit sera to inhibit the AF/R2-dependent bacterial adhesion
to HeLa cells (5). In order to assess whether the protective
effect of doe’s milk could be linked to an inhibiting adhesion
effect in vitro, we adapted this test for milk and lactoserum
samples.
Milk was tested at different dilutions, and we observed a
complete inhibition of bacterial adhesion up to a dilution of 1/4
(Fig. 6A and B). The effect became variable but still important
at the dilution of 1/10 but insignificant at the dilution of 1/50.
A similar pattern of inhibition of adhesion was found when
these experiments were performed with lactoserum (Fig. 6C).
Finally, we wondered whether the inhibition of adhesion was
stable over time during lactation. Milk sampling was done
on days 17, 24, and 30 after birth. For practical reasons, it
was difficult to obtain milk before 2 weeks of lactation. For
this experiment, lactosera were tested at a dilution of 1/4.
The capacity of inhibition of adhesion was observed for all
the kinetic points tested, with an increase at the end of
lactation (day 30), although the differences were not signif-
icant (Fig. 6D).
In order to ensure that this inhibition of adhesion was not
due to the presence of anti-E22 antibodies in the females, the
sera and lactosera of the does were tested for anti-O103 anti-
bodies by an enzyme-linked immunosorbent assay. All does
tested were found to be negative (data not shown). In addition,
sera were tested for their capacity to inhibit adhesion (without
treatment and after the same treatment that was applied to the
milk samples). None of the sera inhibited the adhesion of E22
to HeLa cells (Fig. 6B and data not shown).
Taken together, our results show that the protective effect of
suckling against REPEC infection for young rabbits is associ-
ated with a capacity to inhibit bacterial adhesion to HeLa cells
in vitro. These results suggest that doe’s milk contains one or
several antimicrobial factors whose effects can be detected
both in vivo and in vitro.
DISCUSSION
Here, we provide evidence showing that late weaning may be
desirable to protect fattening rabbits against colibacillosis. In-
deed, we have shown that suckling rabbits are protected
against infection with an EPEC strain that belongs to the O103
serogroup and that is known to be highly virulent (32). When
weaned rabbits are infected by using similar conditions (infec-
tion with a strain from the same serogroup and inoculation at
the same dose and age), the first deaths classically occur 3 to 4
days after inoculation, and a high rate of mortality is reached
in only a few days (4, 8, 17, 23). This corresponds to the pattern
of evolution that we observed in the group W21 rabbits in-
fected at 28 days. Thus, rabbits weaned early do not exhibit
exacerbated sensitivity to this pathogenic strain compared to
rabbits weaned just before the inoculation. It should be also
noted that suckling rabbits presented an atypical pattern of
evolution of colibacillosis. They were protected as long as they
were suckling, but disease (clinical signs, mortality) started to
develop as soon as the rabbits were weaned. Although the
evolution of colibacillosis was less brutal and intense, it was
then quite similar to that in rabbits weaned earlier but had a
time lag compared to that in rabbits weaned earlier. These
observations suggest that milk plays an essential role against
the virulence expression of EPEC.
Several mechanisms of action, probably combined, may
FIG. 5. Milk and lactoserum have bacteriostatic effects on E22 in
vitro. After 5 h of E22 culture, the mean number of CFU for each type
of culture was determined by plating the samples on LB agar plates in
duplicate. The results represent the mean  standard deviation CFU
obtained with the milk and lactosera of seven does.
thereby be suspected. First, the in vivo growth of bacteria may
have been stopped or reduced. Some milk components could
directly exert an antimicrobial effect against pathogenic E. coli
or could indirectly create unfavorable environmental condi-
tions for their growth by modifying the commensal flora, the
pH, or bacterial substrates. This hypothesis seems likely, as
suckling rabbits presented a lower level of excretion of patho-
genic E. coli in their feces until weaning. Moreover, according
to the in vitro tests that we carried out, it seems that a direct
bacteriostatic effect of some milk substances is implicated.
Second, milk could protect against diarrhea by limiting bacte-
rial adhesion to enterocytes. Indeed, the pathogenesis of
EPEC infection starts by a first step of loose adhesion between
bacteria and enterocytes mediated by specific adhesins (13,
16). This hypothesis was confirmed by our results ex vivo that
showed a reduction in the level of adhesion of E22 bacteria to
the ileum of suckling rabbits compared with that in weaned
pups. It was also consistent with our results obtained by using
a recently developed assay of inhibition of AF/R2-dependent
adhesion of EPEC to HeLa cells (5). This assay is based on the
ability of pathogenic E. coli O103 to adhere to HeLa cells in
vitro via the AF/R2 adhesin (30). In this study, inhibition of
adhesion of E. coli to HeLa cells was demonstrated upon
preincubation of the bacteria with milk and lactoserum as well
as after preincubation of milk and lactoserum with HeLa cells
before incubation of the bacteria with epithelial cells (data not
shown). These data suggest that some milk components may
prevent adhesion of the bacteria to enterocytes by acting on
fixation sites from both the bacterial and the epithelial cell
sides. Indeed, the first step of epithelial colonization by E. coli
strains results from the connection between bacterial pili and
surface receptors on host cells. For instance, sialoglycoproteins
act as receptors for the AF/R1 pilus of the rabbit RDEC-1 E.
coli strain (37), and glycosphingolipid and transferrin act as
receptors for the adhesin K88 from some pig enterotoxigenic
E. coli ETEC strains (20). The exact nature of the receptor
specific for AF/R2 has not yet been identified.
Finally, some substances present in milk could interfere with
the mechanisms leading to diarrhea, independently of bacterial
colonization. Indeed, the strong inflammatory response in-
duced by EPEC adhesion to the epithelium is at least partly
responsible for diarrhea (9, 26, 33). Several studies have dem-
onstrated the anti-inflammatory properties of human milk,
which contains regulatory cytokines such as interleukin-10 and
FIG. 6. Milk and lactoserum inhibit bacterial adhesion on HeLa cells in vitro. (A) Milk samples of seven does were tested for their ability to
inhibit bacterial adhesion on HeLa cells. The percentage of pEGFP-E22-positive HeLa cells was determined by flow cytometry by detecting the
green fluorescent protein (gfp) expression of pEGFP-E22. Samplings were done at day 30 after birth. Dilution factors are indicated under each
histogram bar. Data are means  standard deviations. (B) Fluorescence-activated cell sorter histogram visualization of the inhibition of bacterial
adhesion to HeLa cells obtained with lactoserum and serum of a doe at a dilution of 1/4. Similar results were obtained for six other does. Light
black line, E22 and HeLa cells (E22 adhesion, 57.3%); heavy black line, E22 preincubated with lactoserum (E22 adhesion, 4.8%); spotted line, E22
preincubated with the corresponding serum (E22 adhesion, 52.7%). (C) The lactosera of seven does sampled at day 30 after birth were tested for
their ability to inhibit bacterial adhesion on HeLa cells by flow cytometry. The dilution factors are indicated under each histogram bar. Data are
means  standard deviations. (D) The lactosera of four does were tested at different time points of lactation for their ability to inhibit bacterial
adhesion on HeLa cells. All lactosera were tested at a 1/4 dilution. Data are means  standard deviations.
transforming growth factor 
. Indeed, these molecules have
been implicated, for instance, in the protective role of milk in
infant necrotizing colitis (14, 21). In addition, some healing
properties of human milk have also been described, mainly in
association with the presence of epidermal growth factor (14,
25, 35). Interestingly, it has been shown that oral complemen-
tation of young rabbits with epidermal growth factor prevents
the appearance of REPEC-induced diarrhea (6).
The natural virtues of milk in protecting young mammals
against numerous pathogenic viruses and bacteria have been
known for many years (39, 43). A specific passive protection by
maternal antibodies is often responsible for this phenomenon.
However, in this study, the transmission of specific antibodies
by maternal milk was not involved, since all does were sero-
negative for the O103 LPS. More recently, other substances
present in milk have also been shown to have antimicrobial
properties: defensins (19); lactoferrin (42) and its derivative,
the lactoferricin (15); various enzymatic complexes like lac-
toperoxidase, xanthine oxidoreductase, and lysozyme (28, 36,
40); fucosylated oligosaccharides (10); and various fatty acids
(18, 27, 41). It has been suggested that these components could
inactivate pathogens by diverse mechanisms (growth inhibi-
tion, perturbation of adhesion) and may thereby act additively
and/or synergistically (18). In humans, for instance, fucosylated
oligosaccharides and lactoferrin have been shown to inhibit the
localized adhesion of EPEC to HEp-2 and HeLa cells in vitro
(10, 11). So far, the presence of these different components in
doe’s milk has not been demonstrated, although it has been
shown that doe’s milk is free from lactoferrin (29). It would
thus be interesting to characterize the specific antimicrobial
molecules present in doe’s milk.
In conclusion, our work offers interesting prospects for the
identification of the milk components implicated in the control
of colibacillosis and could lead to applications in the agrifood
industry. The findings from this work could also be used in the
future to protect children in developing countries against coli-
bacillosis, a major cause of diarrhea.
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